ID Biomedical goes to war
This article was originally published in Clinica
Executive Summary
ID Biomedical is developing a battlefield gene detection system for the US government. ID, a Canadian company, has been working on a clinical system for detecting the DNA of infectious organisms for some time. It uses a technology known as the cycling probe reaction to amplify target DNA.